Skip to content

Replimune Group REPL Preferred Stock Par Value Per Share

Preferred Stock Par Value Per Share at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0.000.0%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$0.000.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$0.000.0%
GRAIL, Inc. logo
GRAIL, Inc.GRAL
$0.000.0%
Summit Therapeutics logo
Summit TherapeuticsSMMT
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's preferred stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's preferred stock par value per share?
Replimune Group (REPL) reported preferred stock par value per share of $0.00 in Q4 2025.
How has Replimune Group's preferred stock par value per share changed year-over-year?
Replimune Group's preferred stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
What does preferred stock par value per share mean?
The par value per share of preferred stock is a nominal value assigned to preferred shares for accounting and legal purposes. It does not reflect the market value or the liquidation preference of the stock. It is primarily a regulatory and historical accounting figure.